Valuation: Senzime AB

Market Cap 574M 60.12M 52.2M 48.67M 44.71M 84.56M 5.72B 85.49M 224M 2.86B 226M 221M 9.47B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 574M 60.12M 52.2M 48.67M 44.71M 84.56M 5.72B 85.49M 224M 2.86B 226M 221M 9.47B EV / Sales 2026 *
4.49x
EV / Sales 2027 * 2.81x
Free-Float
40.74%
Yield 2026 *
-
Yield 2027 * -
1 day+1.10%
1 week+0.96%
Current month-0.27%
1 month-14.68%
3 months-18.45%
6 months-20.13%
Current year-31.67%
1 week 3.58
Extreme 3.575
4.1
1 month 3.54
Extreme 3.545
4.4
Current year 3.54
Extreme 3.545
6
1 year 3.54
Extreme 3.545
6.99
3 years 3.54
Extreme 3.545
9.6
5 years 2.6
Extreme 2.605
24.8
10 years 2.6
Extreme 2.605
28.5
Manager TitleAgeSince
Chief Executive Officer 53 03/05/2023
Director of Finance/CFO 56 01/01/2022
Chief Tech/Sci/R&D Officer 50 01/01/2023
Director TitleAgeSince
Chairman 53 03/05/2023
Director/Board Member 70 01/01/2016
Director/Board Member 63 05/03/2020
Date Insider Type Main position Quantity % Market Cap.
09/12/25 Buy

Director

15,000 0.0095%
09/12/25 Sell

Director

15,000 0.0095%
28/11/25 Buy

Director

15,900 0.0101%
Change 5-day change 1-year change 3-year change Capi.($)
+0.27%+0.96%-45.41%-24.23% 60.12M
-1.55%-1.69%-18.83%-2.03% 182B
-0.55%-0.78%-3.84%+2.57% 110B
-0.68%-4.16%+4.30%+65.26% 59.59B
-0.10%+8.98%+41.57%+55.00% 55.04B
-0.05%+2.27%-4.91%-37.18% 46.87B
+3.88%+3.78% - - 35.55B
-0.42%+16.15%+14.02%-27.75% 32.81B
+0.24%+3.49%+46.30%-7.01% 24.54B
+0.09%+1.09%+1.93%+3.03% 22.69B
Average +0.21%+3.49%+3.90%+3.07% 57B
Weighted average by Cap. -0.44%+1.55%+0.17%+7.62%

Financials

2026 *2027 *
Net sales 128M 13.38M 11.62M 10.83M 9.95M 18.82M 1.27B 19.03M 49.92M 636M 50.24M 49.14M 2.11B 204M 21.37M 18.56M 17.3M 15.9M 30.06M 2.03B 30.39M 79.75M 1.02B 80.26M 78.5M 3.37B
Net income -68.9M -7.22M -6.27M -5.84M -5.37M -10.15M -687M -10.26M -26.93M -343M -27.11M -26.51M -1.14B -36.8M -3.86M -3.35M -3.12M -2.87M -5.42M -367M -5.48M -14.39M -183M -14.48M -14.16M -607M
Net Debt - -
Logo Senzime AB
Senzime AB (publ.) is a Sweden-based company engaged in the development, manufacture and marketing of biosensors for measuring metabolites in biological fluids, such as human blood and cell culture substrates for the pharmaceutical and healthcare segments. The Company focuses on the following application areas: medical diagnostic instruments, pharmaceutical industry, chemical processing, and food and beverage processing. As of December 31, 2011, the Company marketed three products, namely SENZ-100G, for continuous analysis of glucose in the fermentation solutions; SENZ-100L, for continuous analysis of lactate in fermentation solutions, and SENZ-200G, for continuous analysis of glucose in blood during intensive care.
Employees
59
Date Price Change Volume
05/08/26 SEK 3.660 +0.27% 640,913
04/08/26 SEK 3.650 0.00% 102,827
03/08/26 SEK 3.650 -1.35% 101,833
31/07/26 SEK 3.700 0.00% 119,337
30/07/26 SEK 3.700 +1.23% 39,070

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SEZI Stock